G. Sinha

发表

Cell presses

G. Sinha, 2014, Nature Biotechnology.

Up in arms

G. Sinha, 2009, Nature Biotechnology.

Decision aids help patients but still are not widely used.

G. Sinha, 2014, Journal of the National Cancer Institute.

Interest resparks in RNAi

G. Sinha, 2012, Nature Biotechnology.

Antisense battles small molecule for slice of rare lipid disorder market

G. Sinha, 2013, Nature Biotechnology.

Colorectal cancer survivors need better follow-up care.

G. Sinha, 2014, Journal of the National Cancer Institute.

Electronic health records help recruit trial participants and track drug safety.

Gunjan Sinha, G. Sinha, 2008, Journal of the National Cancer Institute.

Academia's $1,000 genome

G. Sinha, 2011, Nature Biotechnology.

Drug companies accused of stalling tailored therapies

G. Sinha, 2006, Nature Medicine.

Leptin therapy gains FDA approval

G. Sinha, 2014, Nature Biotechnology.

Expensive cancer drugs with modest benefit ignite debate over solutions.

G. Sinha, 2008, Journal of the National Cancer Institute.

EU law mandates drug testing in children.

G. Sinha, 2008, Journal of the National Cancer Institute.

News Feature: A lab of her own

G. Sinha, C. Schubert, 2004, Nature Medicine.

A lab of her own.

G. Sinha, C. Schubert, 2004, Nature medicine.

Sanofi's dengue vaccine first to complete phase 3

G. Sinha, 2014, Nature Biotechnology.

European move affects academic trials research.

G. Sinha, 2006, Journal of the National Cancer Institute.

Ablynx drops lead nanobody

G. Sinha, 2012, Nature Biotechnology.

Training the Brain

G. Sinha, 2005 .

Training the brain. Cognitive therapy as an alternative to ADHD drugs.

G. Sinha, 2005, Scientific American.

Coalition aims to accelerate translation of cell therapies

G. Sinha, 2012, Nature Biotechnology.

European Union creates its own "critical path".

G. Sinha, 2007, Journal of the National Cancer Institute.

Recurrent Oral Ulcers and Its Association With Stress Among Dental Students in the Northeast Indian Population: A Cross-Sectional Questionnaire-Based Survey

G. Sinha, K. Shalini, K. Srikrishna, 2023, Cureus.

Peering inside Alzheimer's brains

G. Sinha, 2011, Nature Biotechnology.

Taiwanese scientists brace for second season of SARS

G. Sinha, Y. Chiu, 2003, Nature Medicine.

Doubt cast on inflammation’s stop signals

G. Sinha, 2022, Science.

Roche bets on alpha-synuclein for Parkinson's

G. Sinha, 2014, Nature Biotechnology.

GM Technology Develops in the Developing World

G. Sinha, 2007, Science.

EU mAb biosimilars path

G. Sinha, 2011, Nature Biotechnology.

Homing in on the fat and cancer connection.

G. Sinha, 2012, Journal of the National Cancer Institute.

United Kingdom becomes the cancer clinical trials recruitment capital of the world.

Gunjan Sinha, G. Sinha, 2007, Journal of the National Cancer Institute.

Agile collaboration: Citizen science as a transdisciplinary approach to heliophysics

Thomas Y. Chen, G. Sinha, D. Ozturk, 2023, Frontiers in Astronomy and Space Sciences.

Spat over IMI funding and intellectual property

G. Sinha, 2011, Nature Biotechnology.

Downfall of iniparib: a PARP inhibitor that doesn't inhibit PARP after all.

Gunjan Sinha, G. Sinha, 2014, Journal of the National Cancer Institute.

Regado's aptamer lines up against anticoagulants

G. Sinha, 2013, Nature Biotechnology.

Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to India.

G. Sinha, 2004, Scientific American.

Outsourcing drug work.

G. Sinha, 2004 .

An electromyographic evaluation of orbicularis oris and masseter muscle in pretreatment and posttreatment patients of oral submucous fibrosis: A prospective study

C. Ram, G. Sinha, Manisha Sharma, 2018, Journal of Indian Academy of Oral Medicine and Radiology.

Listeria vaccines join the checkpoint frenzy

G. Sinha, 2014, Nature Biotechnology.

Human Embryonic Stem Cells May Be Toxicology's New Best Friends

G. Sinha, 2005, Science.

More evidence that aspirin lowers cancer risk.

G. Sinha, 2015, Journal of the National Cancer Institute.

Gaucher's disease oral therapy gets nod from FDA

G. Sinha, 2014, Nature Biotechnology.

Another blow for ALS

G. Sinha, 2013, Nature Biotechnology.

Bovine Leukemia Virus Possibly Linked to Breast Cancer.

G. Sinha, 2016, Journal of the National Cancer Institute.

Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles.

G. Sinha, R. Barst, S. Itescu, 1996, American journal of respiratory and critical care medicine.

News Feature: Medicine of the masses

G. Sinha, 2005, Nature Medicine.

Pfizer and Lilly shoulder novel pain-drug risks

G. Sinha, 2014, Nature Biotechnology.

User friendliness, efficiency & spray quality of stirrup pumps versus hand compression pumps for indoor residual spraying

G. Sinha, S. Hussain, S. Kesari, 2013, The Indian journal of medical research.